Home・Aktien・Sanofi

Sanofi

Geschlossen

44.84 -2.54

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

45.38

Max

46.03

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.3B 343M
Verkäufe	1.1B 12B
KGV Branchendurchschnitt	24.303 57.366
EPS	1.21
Dividendenrendite	8.99
Gewinnspanne	2.789
Angestellte	74,846
EBITDA	-1B 1.7B

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+21.69% upside

Dividenden
By Acuity
Dividendenrendite Branchendurchschnitt	8.99% 2.16%

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	4.7B 109B
Vorheriger Eröffnungskurs	47.38
Vorheriger Schlusskurs	44.84

Sanofi Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Aug. 2026, 23:56 UTC

Correlated Moves

Emerson Electric Co's shares are lower in after-market hours, reflecting a decline since Tuesday's close amid broader market sentiment influencing the stock's movement.

25. Aug. 2026, 23:56 UTC

Charles River Laboratories shares are higher in after-market trading, maintaining a position near the upper end of their one-month range amid lower crude oil prices.

25. Aug. 2026, 23:56 UTC

Host Hotels and Resorts, Inc. shares are lower in after-market hours. No specific news was identified to explain the decline, amid falling crude oil prices.

25. Aug. 2026, 23:56 UTC

Correlated Moves

KKR & Co Inc shares are lower in after-market hours, reflecting broader trends in the financial sector amid minimal change since Tuesday's close.

25. Aug. 2026, 23:56 UTC

ETF Constituents

Correlated Moves

Vanguard Morningstar Mid-Cap ETF trades higher after-market, supported by contributions from HWM, PWR, VST, NET, and LHX amid a rising Russell 2000 Index.

25. Aug. 2026, 23:56 UTC

Correlated Moves

M&T Bank Corp shares are lower in after-market trading, influenced by a decline in Wells Fargo and broader market sentiment affecting the banking sector.

25. Aug. 2026, 23:56 UTC

Allogene Therapeutics Inc. is trading roughly flat in after-market hours, maintaining a position near the upper end of its one-month range.

25. Aug. 2026, 23:56 UTC

Correlated Moves

NiSource Inc shares are trading lower in after-market hours, influenced by a decline in Sempra and broader market sentiments affecting utility stocks.

25. Aug. 2026, 23:56 UTC

Toast Inc shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

25. Aug. 2026, 23:56 UTC

Baker Hughes Co's shares are higher in after-market trading, with no specific news identified. Broader market trends may be influencing positive sentiment.

25. Aug. 2026, 23:56 UTC

Correlated Moves

Johnson Controls International PLC shares rose in after-market trading, reflecting modest gains amid favorable investor sentiment and a correlation with nVent Electric PLC.

25. Aug. 2026, 23:56 UTC

Correlated Moves

Public Service Enterprise Group Inc. sees modest gains in after-market trading, aligning with broader trends from related companies like DTE Energy Co.

25. Aug. 2026, 23:56 UTC

Correlated Moves

Shares of APA Corp declined in after-market trading, continuing a trend of lower daily finishes, amid falling WTI crude oil prices.

25. Aug. 2026, 23:56 UTC

Fidelity National Information Services shares are trading lower in after-market hours. The asset remains below its 20-day moving average.

25. Aug. 2026, 23:56 UTC

Williams Companies Inc. shares are higher in after-market trading, reflecting a slight gain since Tuesday's close amid declining crude oil prices and lower treasury yields.

25. Aug. 2026, 23:56 UTC

Diamondback Energy shares traded roughly flat in after-market hours, following four consecutive sessions of declines amid lower crude oil prices and treasury yields.

25. Aug. 2026, 23:56 UTC

Correlated Moves

Fifth Third Bancorp remains roughly flat in after-market trading, despite a slight increase in the Dow Jones Index and declining crude oil prices.

25. Aug. 2026, 23:56 UTC

Correlated Moves

Jones Lang LaSalle Inc shares are lower in after-market trading, reflecting a broader decline in the real estate sector alongside Marcus & Millichap Inc.

25. Aug. 2026, 23:52 UTC

Mexico's Business Confidence Remains Low at 48.0 Ahead of Key Survey Amid Mixed Trade Sentiments with the U.S.

25. Aug. 2026, 23:52 UTC

Brazil's Q2 2026 GDP Growth Rate Release Looms Amid Declining Consumer Confidence and Cautious Market Sentiment.

25. Aug. 2026, 23:52 UTC

Brazil's Q2 2026 GDP growth release on September 1 expected to reflect strong government spending amid mixed consumer confidence and rising inflation concerns.

25. Aug. 2026, 23:52 UTC

India's Current Account Balance Release on September 1, 2026 Expected to Impact Market Sentiment Amid Rising Import Costs and Geopolitical Pressures.

25. Aug. 2026, 23:52 UTC

Brazil's Central Bank to Announce SELIC Rate Decision Amid Global Monetary Policy Uncertainty on August 31, 2026.

25. Aug. 2026, 23:52 UTC

Social Media

Warner Bros Discovery Inc shares traded lower in after-market hours amid ongoing scrutiny in the antitrust case involving Paramount and related legal developments.

25. Aug. 2026, 23:52 UTC

UniFirst Corp shares declined in after-market trading, despite a favorable macro environment with falling crude oil prices and lower Treasury yields.

25. Aug. 2026, 23:51 UTC

DraftKings shares are higher in after-market trading amid favorable market conditions and a decline in crude oil prices. No specific news was identified.

25. Aug. 2026, 23:51 UTC

Travel + Leisure Co shares are higher in after-market hours. No specific company news was identified, but declining crude oil prices may be influencing sentiment.

25. Aug. 2026, 23:51 UTC

Correlated Moves

American Water Works shares are higher in after-market trading, supported by a decline in crude oil prices and easing inflation concerns.

25. Aug. 2026, 23:51 UTC

Asia equity markets mixed as investors react to geopolitical tensions, falling crude oil prices, and await key U.S. economic data releases.

25. Aug. 2026, 23:51 UTC

Mixed trading in Europe as Germany's Ifo index rises, while France's consumer confidence dips; U.S. markets gain on falling oil prices and tech stock rallies ahead of key earnings.

Peer-Vergleich

Kursveränderung

Sanofi Prognose

Kursziel

By TipRanks

21.69% Vorteil

12-Monats-Prognose

Durchschnitt 56 USD 21.69%

Hoch 62 USD

Tief 49 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Sanofi – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Sanofi – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.